IRIS Accounts Production v25.1.3.33 09380928 Board of Directors 1.2.24 30.9.24 30.9.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh093809282024-01-31093809282024-09-30093809282024-02-012024-09-30093809282023-01-31093809282023-02-012024-01-31093809282024-01-3109380928ns15:EnglandWales2024-02-012024-09-3009380928ns14:PoundSterling2024-02-012024-09-3009380928ns10:Director12024-02-012024-09-3009380928ns10:PrivateLimitedCompanyLtd2024-02-012024-09-3009380928ns10:SmallEntities2024-02-012024-09-3009380928ns10:AuditExempt-NoAccountantsReport2024-02-012024-09-3009380928ns10:SmallCompaniesRegimeForDirectorsReport2024-02-012024-09-3009380928ns10:SmallCompaniesRegimeForAccounts2024-02-012024-09-3009380928ns10:FullAccounts2024-02-012024-09-3009380928ns10:Director22024-02-012024-09-3009380928ns10:CompanySecretary12024-02-012024-09-3009380928ns10:RegisteredOffice2024-02-012024-09-3009380928ns5:CurrentFinancialInstruments2024-09-3009380928ns5:CurrentFinancialInstruments2024-01-3109380928ns5:Non-currentFinancialInstruments2024-09-3009380928ns5:Non-currentFinancialInstruments2024-01-3109380928ns5:ShareCapital2024-09-3009380928ns5:ShareCapital2024-01-3109380928ns5:RetainedEarningsAccumulatedLosses2024-09-3009380928ns5:RetainedEarningsAccumulatedLosses2024-01-3109380928ns5:PlantMachinery2024-02-012024-09-3009380928ns5:PlantMachinery2024-01-3109380928ns5:PlantMachinery2024-09-3009380928ns5:PlantMachinery2024-01-3109380928ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-01-3109380928ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-02-012024-09-3009380928ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-09-3009380928ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-01-3109380928ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3009380928ns5:WithinOneYearns5:CurrentFinancialInstruments2024-01-3109380928ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2024-09-3009380928ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:HirePurchaseContracts2024-01-3109380928ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2024-09-3009380928ns5:BetweenOneFiveYearsns5:HirePurchaseContracts2024-01-3109380928ns5:HirePurchaseContracts2024-09-3009380928ns5:HirePurchaseContracts2024-01-3109380928ns5:WithinOneYear2024-09-3009380928ns5:WithinOneYear2024-01-3109380928ns5:BetweenOneFiveYears2024-09-3009380928ns5:BetweenOneFiveYears2024-01-3109380928ns5:AllPeriods2024-09-3009380928ns5:AllPeriods2024-01-3109380928ns5:DeferredTaxation2024-01-3109380928ns5:DeferredTaxation2024-02-012024-09-3009380928ns5:DeferredTaxation2024-09-30
REGISTERED NUMBER: 09380928 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 1 FEBRUARY 2024 TO 30 SEPTEMBER 2024

FOR

J T GRIFFITHS MEDICAL LIMITED

J T GRIFFITHS MEDICAL LIMITED (REGISTERED NUMBER: 09380928)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 FEBRUARY 2024 TO 30 SEPTEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


J T GRIFFITHS MEDICAL LIMITED

COMPANY INFORMATION
FOR THE PERIOD 1 FEBRUARY 2024 TO 30 SEPTEMBER 2024







DIRECTORS: Dr J T Griffiths
Dr A G Griffiths





SECRETARY: Dr J T Griffiths





REGISTERED OFFICE: Larch House
Parklands Business Park
Denmead
Hampshire
PO7 6XP





REGISTERED NUMBER: 09380928 (England and Wales)





ACCOUNTANTS: Gibson Whitter
Chartered Accountants
and Chartered Tax Advisers
Larch House
Parklands Business Park
Denmead
Hampshire
PO7 6XP

J T GRIFFITHS MEDICAL LIMITED (REGISTERED NUMBER: 09380928)

BALANCE SHEET
30 SEPTEMBER 2024

30.9.24 31.1.24
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 28,166 77,379

CURRENT ASSETS
Debtors 5 493,717 490,004
Cash at bank 519,915 187,891
1,013,632 677,895
CREDITORS
Amounts falling due within one year 6 256,624 112,239
NET CURRENT ASSETS 757,008 565,656
TOTAL ASSETS LESS CURRENT
LIABILITIES

785,174

643,035

CREDITORS
Amounts falling due after more than one
year

7

-

(86,720

)

PROVISIONS FOR LIABILITIES 10 (7,041 ) (19,345 )
NET ASSETS 778,133 536,970

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 778,033 536,870
778,133 536,970

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

J T GRIFFITHS MEDICAL LIMITED (REGISTERED NUMBER: 09380928)

BALANCE SHEET - continued
30 SEPTEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved and authorised for issue by the Board of Directors and authorised for issue on 20 May 2025 and were signed on its behalf by:





Dr J T Griffiths - Director


J T GRIFFITHS MEDICAL LIMITED (REGISTERED NUMBER: 09380928)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 FEBRUARY 2024 TO 30 SEPTEMBER 2024

1. STATUTORY INFORMATION

J T Griffiths Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery etc - 33% on cost

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 2 (2024 - 2 ) .

J T GRIFFITHS MEDICAL LIMITED (REGISTERED NUMBER: 09380928)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 FEBRUARY 2024 TO 30 SEPTEMBER 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 February 2024 124,600
Disposals (60,077 )
At 30 September 2024 64,523
DEPRECIATION
At 1 February 2024 47,221
Charge for period 6,482
Eliminated on disposal (17,346 )
At 30 September 2024 36,357
NET BOOK VALUE
At 30 September 2024 28,166
At 31 January 2024 77,379

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:

Plant and
machinery
etc
£   
COST
At 1 February 2024 115,165
Disposals (56,975 )
At 30 September 2024 58,190
DEPRECIATION
At 1 February 2024 39,702
Charge for period 5,455
Eliminated on disposal (14,244 )
At 30 September 2024 30,913
NET BOOK VALUE
At 30 September 2024 27,277
At 31 January 2024 75,463

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 31.1.24
£    £   
Trade debtors 10,408 25,077
Other debtors 483,309 464,927
493,717 490,004

J T GRIFFITHS MEDICAL LIMITED (REGISTERED NUMBER: 09380928)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 FEBRUARY 2024 TO 30 SEPTEMBER 2024

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 31.1.24
£    £   
Hire purchase contracts (see note 8) 32,336 7,648
Taxation and social security 198,673 98,215
Other creditors 25,615 6,376
256,624 112,239

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30.9.24 31.1.24
£    £   
Hire purchase contracts (see note 8) - 86,720

8. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Hire purchase contracts
30.9.24 31.1.24
£    £   
Net obligations repayable:
Within one year 32,336 7,648
Between one and five years - 86,720
32,336 94,368

Non-cancellable operating leases
30.9.24 31.1.24
£    £   
Within one year 9,250 -
Between one and five years 10,793 -
20,043 -

9. SECURED DEBTS

The following secured debts are included within creditors:

30.9.24 31.1.24
£    £   
Hire purchase contracts 32,336 94,368

The hire purchase contracts are secured against the assets being financed.

10. PROVISIONS FOR LIABILITIES
30.9.24 31.1.24
£    £   
Deferred tax 7,041 19,345

J T GRIFFITHS MEDICAL LIMITED (REGISTERED NUMBER: 09380928)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 FEBRUARY 2024 TO 30 SEPTEMBER 2024

10. PROVISIONS FOR LIABILITIES - continued

Deferred
tax
£   
Balance at 1 February 2024 19,345
Utilised during period (12,304 )
Balance at 30 September 2024 7,041

11. RELATED PARTY TRANSACTIONS

At the year end the company owed the directors: £22,805 (31.1.24: £4,972).

Included within other debtors is an amount owed by a connected company £476,506 (31.1.24: £462,916)

12. ULTIMATE CONTROLLING PARTY

The controlling parties are Dr A G Colvin and Dr J T Griffiths by virtue of their shareholding.